Get the Stockscreener App
1.405
0.35%
-0.005
After Hours:
1.41
0.005
+0.36%
Molecular Templates Inc stock is traded at $1.405, with a volume of 22,956.
It is down -0.35% in the last 24 hours and down -8.17% over the past month.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
See More
Previous Close:
$1.41
Open:
$1.32
24h Volume:
22,956
Relative Volume:
0.84
Market Cap:
$9.25M
Revenue:
$52.63M
Net Income/Loss:
$-8.12M
P/E Ratio:
-0.1129
EPS:
-12.45
Net Cash Flow:
$-42.02M
1W Performance:
+9.77%
1M Performance:
-8.17%
6M Performance:
-37.28%
1Y Performance:
-77.77%
1-Day Range:
$1.32
$1.4099
1-Week Range:
$1.22
$1.41
52-Week Range:
$1.00
$6.93
Molecular Templates Inc Stock (MTEM) Company Profile
Name
Molecular Templates Inc
Sector
Industry
Phone
512 896 1555
Address
9301 AMBERGLEN BLVD, AUSTIN, TX
Molecular Templates Inc Stock (MTEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-21 | Initiated | BofA Securities | Buy |
| Feb-01-21 | Initiated | UBS | Neutral |
| Sep-08-20 | Initiated | Jefferies | Buy |
| Mar-25-20 | Initiated | Stifel | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Apr-29-19 | Initiated | UBS | Buy |
| Dec-11-18 | Initiated | Oppenheimer | Outperform |
| Oct-08-18 | Initiated | Laidlaw | Buy |
View All
Molecular Templates Inc Stock (MTEM) Latest News
Molecular Templates holds annual stockholder meeting - Investing.com
Molecular Templates holds annual stockholder meeting By Investing.com - Investing.com UK
Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More News - BioSpace
Commonwealth Equity Services LLC Has $979,000 Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Stock: Take Profits While The Valuation Is Sky High (NASDAQ:TMDX) - Seeking Alpha
Traws Pharma Announces Stock Split, Share Adjustments, and Growth Strategy - TipRanks
Traws Pharma, Inc. Announces Special Shareholders Meeting Results - GlobeNewswire
Transmedics Group Inc (TMDX) deserves deeper analysis - US Post News
Tactile Medical's Shares Rise After PDAC Approval for Nimbl - Zacks Investment Research
An analyst sees good growth prospects for Transmedics Group Inc (TMDX) - SETE News
Tactile Medical's new Nimbl system approved for Medicare billing - Investing.com
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Global Market for In-vitro Transcription Templates to Grow at 19.53% CAGR As Revealed In New Report - WhaTech
Analyzing Molecular Templates Inc (MTEM) After Recent Trading Activity - Knox Daily
Centuri Holdings Inc. [CTRI] Investment Guide: What You Need to Know - Knox Daily
Stock Market Movers Today • Top Gainers & Losers - Benzinga
MTEM stock touches 52-week low at $1 amid market challenges - Investing.com Australia
MTEM stock touches 52-week low at $1 amid market challenges - Investing.com
MTEM stock touches 52-week low at $1 amid market challenges - Investing.com Canada
Who are the leading innovators in polysaccharide-protein conjugate vaccines for the pharmaceutical industry? - Pharmaceutical Technology
Molecular Templates, Inc. announced that it has received $12 million in funding from Excel Venture Management, Santé Ventures, LLC, AJU IB INVESTMENT Co., Ltd.. - Marketscreener.com
Earnings Release: Here's Why Analysts Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Price Target To US$18.00 - Simply Wall St
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update - wallstreet:online
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update - Yahoo Finance
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update - StockTitan
MTEM (Molecular Templates) Debt-to-EBITDA : 1.32 (As of Mar. 2024) - GuruFocus.com
Game-Changing BCL-2 Inhibitors Set to Revolutionize Cancer Treatment Market | DelveInsight - India Shorts
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
Who are the leading innovators in anti-HPV compositions for the pharmaceutical industry? - Pharmaceutical Technology
Molecular Templates, Inc.'s (NASDAQ:MTEM) Shares Bounce 27% But Its Business Still Trails The Industry - Simply Wall St
Biopharma Layoff Tracker 2024: Cue, Anokion, GlycoMimetics and More Cut Staff - BioSpace
Companies - BioSpace
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff - BioSpace
Short Interest in Ovintiv Inc. (NYSE:OVV) Decreases By 30.8% - Defense World
Brookfield Property Preferred (NASDAQ:BPYPM) Stock Price Up 2.8% - Defense World
Need To Know: The Consensus Just Cut Its Molecular Templates, Inc. (NASDAQ:MTEM) Estimates For 2022 - Yahoo Canada Sports
Molecular Templates Provides Corporate Update And Outlines 2022 Milestones - Barchart
Molecular Templates Inc Stock (MTEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):